advertisement
The efficacy of cortexine used to treat patients with unstabilized primary open-angle glaucoma (OAG) was studied after penetrating through trophic sclerectomy with cyclodialysis. Thirty-nine patients (58 eyes) with developed OAG were examined. All the patients underwent penetrating trophic sclerectomy with cyclodialysis, followed by a course of subconjunctival injections of cortexine 10 mg. The positive effect persisted for 1.5 years and a stabilizing glaucomic process was observed in 78% of the patients.
A.L. Shtilerman.
11.14 Investigational drugs; pharmacological experiments (Part of: 11 Medical treatment)
12.11 Cyclodialysis (Part of: 12 Surgical treatment)